Effect of Low-Volume HIT vs. MIC Exercise in Individuals With Increased BMI
Effect of Low-Volume High-Intensity Training vs. Moderate Intensity Continuous Exercise on Rate Pressure Product and Functional Capacity in Individuals With Increased BMI
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Some recent studies suggest that the rising interest for the potential of high- intensity interval training (HIIT) to enhance the metabolic health in overweight adults. HIIT has also been found to induce comparatively fast enhancements in overall-body aerobic capacity and muscle mitochondrial markers in individuals with overweight.
The main advantage of HIIT is that low-volume HIIT protocols can involve a shorter time as compared with MICT, and time limitations have been recognized as a generally reported hurdle to daily exercise involvement.
Latest studies propose that's when compared to moderate intensity continuous training (MICT), HIIT has been shown to produce similar and sometimes better improvements in results such as cardiorespiratory fitness in spite of often demanding a smaller amount of time commitment and lesser energy expenditure. On the other hand, low volume HIIT is still undecided whether this form of physical training is superior, equivalent or inferior to more outdated forms of exercise training such as MICT for the management cardio metabolic health.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 46060
- Cantonment General Hospital, Saddar
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Body mass index 23-29.9 kg/m 2 (Overweight-Type I Obese)
- Able to do exercise (PAR-Q)
Exclusion Criteria:
- History of chronic diseases and medication use
- Considerable mental or physical disability, neurological or musculoskeletal problems
- Severe personality disorders or drug addiction.
- Pregnant females
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low-volume High intensity interval training
Group A: Low-volume High intensity interval training
|
Week 1 & 2: Warm-up: 10 minutes at 50% THR Work: 1x4 minutes at 80% THR followed by 1*4 minutes Recovery at 50% THR Cool down: 5 minutes at 50% THR Total exercise time: 23 minutes Week 3 & 4: Warm-up: 10 minutes at 50% THR Work: 2x6 minutes at 80% THR followed by 1*6 minutes Recovery at 50% THR Cool down: 5 minutes at 50% THR Total exercise time: 33 minutes |
|
Experimental: Moderate intensity continous exercise
Group B: Moderate intensity continous exercise
|
Week 1 & 2: Warm-up: 5 minutes at 50% THR Work: 20 minutes at 60% VO 2 THR Cool Down: 5 minutes at 50% THR Total exercise time: 30 minutes Week 3 & 4: Warm-up: 5 minutes at 50% THR Work: 30 minutes at 60% THR Cool Down: 5 minutes at 50% THR Total exercise time: 40 minutes |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate Pressure Product
Time Frame: 2 weeks, 4 weeks
|
Changes from baseline to 2 weeks and 4 weeks after the intervention, measured through product of heart rate and systolic blood pressure, is a very reliable indicator of myocardial oxygen demand.
An RPP above 20,000 mmHg per minute is considered healthy, whereas anything below 16,000 mmHg is considered insufficient.
|
2 weeks, 4 weeks
|
|
Functional Capacity
Time Frame: 2 Weeks, 4 Weeks
|
Changes from baseline to 2 weeks and 4 weeks after the intervention, measured through 6 min walk test (6 MWT).
It is a submaximal exercise test that can aid in assessing the functional/exercise capacity of patients with cardiopulmonary diseases, in this test we find out the maximum distance in meters that an individual covers in 6 min without any support.
|
2 Weeks, 4 Weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mehwish Waseem, MSPT-CPPT, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Rec/01817 Asma Rehman
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.